Page last updated: 2024-09-04

docetaxel anhydrous and sermorelin

docetaxel anhydrous has been researched along with sermorelin in 1 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (sermorelin)	Trials (sermorelin)	Recent Studies (post-2010) (sermorelin)
12,110	3,216	6,920	305	29	64

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buchholz, S; Engel, JB; Hohla, F; Ortmann, O; Rick, FG; Schally, AV; Seitz, S; Szalontay, L; Treszl, A; Zarandi, M	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and sermorelin

Article	Year
Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers. Oncology reports, 2013, Volume: 30, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Female; Growth Hormone-Releasing Hormone; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; Sermorelin; Taxoids; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2013

Article

Year

Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.

Oncology reports, 2013, Volume: 30, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Female; Growth Hormone-Releasing Hormone; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; Sermorelin; Taxoids; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2013